Welcome to Cosmo Pharmaceuticals
Cosmo is a speciality pharmaceutical company that aims to become
a global leader in the market of optimised therapies for selected
gastro-intestinal diseases. The company’s proprietary
clinical development pipeline specifically addresses innovative
treatments for Gastro-intestinal diseases, specifically
Inflammatory Bowel Diseases (IBD), colon infections and colon
diagnosis, as well as selected topically treated Skin
Disorders.
Product Pipeline
The company is developing a range of pharmaceutical product projects that are mostly based on its
Multi Matrix MMX® technology.
Find out more
Therapeutic Focus
Inflammatory Bowel Diseases (IBD) are a group of chronic, progressive, recurring and debilitating inflammatory processes of the gastro-intestinal tract mainly represented by Ulcerative Colitis and Crohn’s Disease. Both diseases are clinically similar and may be described as a faulty regulation of the mucosal immune response.
Business Fields
Cosmo is engaged in two distinct fields:
- Development and commercialisation of proprietary pharmaceutical products, primarily focused on the treatment of Inflammatory Bowel Diseases, colon infections as well as colon disease diagnosis.
- Manufacturing of pharmaceutical products for third parties and the provision of related services.